Related Experiment Video
Updated: Apr 23, 2026

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
Hendra virus genotypes 1 and 2 differ in V protein-mediated immune evasion
Melanie N Tripp1,2, Stephen M Rawlinson1, Sarah J Edwards2
1Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
Hendra virus (HeV) genotype 1 V protein is a more potent interferon antagonist than genotype 2, explaining differences in disease severity. This study reveals key biological distinctions between HeV genotypes impacting pathogenesis.
Area of Science:
- Virology
- Immunology
- Pathogenesis
Background:
- Hendra virus (HeV) causes lethal infections in horses and humans.
- Two genotypes, HeV-g1 and HeV-g2, exhibit different disease severities.
- The V protein is a key virulence factor and differs between genotypes.
Purpose of the Study:
- To compare the interferon (IFN) antagonist functions of HeV-g1 V and HeV-g2 V proteins.
- To understand molecular mechanisms behind differing HeV genotype pathogenesis.
Main Methods:
- Compared IFN antagonist activity of HeV-g1 V and HeV-g2 V.
- Assessed nucleocytoplasmic localization of V proteins.
- Measured type-I IFN production during HeV infection.
Main Results:
- HeV-g1 V is a more potent antagonist of type-I IFN induction than HeV-g2 V.
- HeV-g1 and HeV-g2 V proteins exhibit different nucleocytoplasmic localization.
- HeV-g1 infection suppressed type-I IFN production more effectively than HeV-g2.
Conclusions:
- Differences in V protein IFN antagonist activity contribute to pathogenesis variations between HeV genotypes.
- Nucleocytoplasmic localization of V proteins may influence their function.
- These findings highlight significant biological differences between HeV genotypes.
More Related Videos
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
Related Concept Videos
Leaky Scanning
Viruses with RNA Genomes
Arboviral Encephalitis